ArticleHuman vaccines & immunotherapeutics2014

Engineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.

Anton Beletskii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.